Governance Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 10/12/2025 GMT			5-day change	1st Jan Change
993.64 ^USD	+1.16%		-3.86%	+28.71%

12-10	Health Care Up on Earnings Optimism - Health Care Roundup	DJ
12-10	Global markets live: Nvidia, Amazon, Eli Lilly, Intel, Airbus…

Executive Committee: Eli Lilly and Company

Manager

Positions heldSince

David Ricks

57 year

Chief Executive Officer	31/12/2016
President	31/12/2016

Ruth Gimeno

President

Eric Dozier

58 year

Human Resources Officer

30/08/2022

David Hyman

Chief Tech/Sci/R&D Officer

15/10/2023

Diogo Rau

50 year

Chief Tech/Sci/R&D Officer

16/05/2021

Donald Zakrowski

Comptroller/Controller/Auditor

31/10/2012

Daniel Skovronsky

51 year

Chief Tech/Sci/R&D Officer

Lucas Montarce

48 year

Director of Finance/CFO

08/09/2024

Anat Hakim

55 year

General Counsel	02/02/2020
Corporate Secretary	-

Composition of the Board of Directors: Eli Lilly and Company

Director

CommitteesSince

David Ricks

57 year

Compensation Committee

11/04/2018

Ralph Alvarez

69 year

Audit Committee
Compensation Committee Chair
Compensation Committee
Governance Committee
Nominating Committee

Carolyn Bertozzi

58 year

Governance Committee	31/10/2022
Nominating Committee	31/10/2022
Compensation Committee
HR Committee

Gabrielle Greene-Sulzberger

64 year

Audit Committee	24/01/2021
Governance Committee
Nominating Committee	30/11/2018

Mary Lynne Hedley

62 year

Governance Committee Chair	15/08/2019
Nominating Committee Chair	15/08/2019
Audit Committee	22/02/2021

Jamere Jackson

55 year

Governance Committee	30/09/2016
Audit Committee Chair	30/09/2016

Juan Luciano

63 year

Compensation Committee
Governance Committee Chair

Jon Moeller

61 year

Audit Committee	30/11/2024
Governance Committee	30/11/2024

William Kaelin

67 year

Governance Committee

Kimberly Johnson

52 year

Compensation Committee

15/02/2021

Jon Fyrwald

65 year

Compensation Committee

Katherine Baicker

53 year

Director/Board Member	11/12/2011
Independent Dir/Board Member	11/12/2011

Latest Appointments: Eli Lilly and Company

12-08	Carolyn Bertozzi returns to Lilly board of directors	RE
12-03	Alnylam Pharmaceuticals Announces Changes to Board of Directors	CI
11-21	Eli Lilly & Co elects Carolyn R. Bertozzi to board - SEC filing	RE
11-21	Eli Lilly and Company Announces Appointment of Carolyn R. Bertozzi, Ph.D as New Board Member and Member of Science and Technology Committee and the Ethics and Compliance Committee, Effective December 8, 2025	CI
11-17	Nxera Pharma Co., Ltd. Announces Executive Changes	CI
11-14	Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip	RE
11-12	Gate Bioscience, Inc. announced that it has received $64.999995 million in funding from Forbion Capital Partners B.V., Eli Lilly and Company, Versant Venture Management, LLC, Andreessen Horowitz LLC, GV Management Company, LLC, Arch Venture Partners, L.P.	CI

More news

Former Officers and Directors: Eli Lilly and Company

Insider

Positions held

SinceUntil

Kathi P. Seifert

Director/Board Member	31/12/1994	02/05/2021
Independent Dir/Board Member	31/12/1994	02/05/2021

Ellen Marram

Director/Board Member	31/12/2001	30/04/2019
Chairman	08/05/2013	07/07/2013
Independent Dir/Board Member	31/12/2011	30/04/2019

John Lechleiter

Director/Board Member	31/12/2004	31/12/2008
Chief Executive Officer	31/03/2008	30/12/2016
Chairman	31/12/2008	30/05/2017
Chief Operating Officer	31/12/2004	31/03/2008
General Counsel	31/12/1993	31/12/1997
Corporate Officer/Principal	31/12/1997	31/12/2004
President	31/12/2004	30/12/2016

Derica Rice

Comptroller/Controller/Auditor	31/12/2002	31/12/2005
Director of Finance/CFO	31/12/2005	31/12/2016

Franklyn Prendergast

Director/Board Member	31/03/1995	31/12/2016
Independent Dir/Board Member	31/03/1995	31/12/2016

Karen Horn

Director/Board Member	31/12/1986	01/05/2016
Independent Dir/Board Member	14/04/2011	01/05/2016

Win Bischoff

Director/Board Member	31/03/2000	04/05/2014
Independent Dir/Board Member	24/04/2011	04/05/2014

Robert A. Armitage

Director/Board Member	25/04/2011	04/05/2011
General Counsel	31/10/1999	30/12/2012

Arnold Hanish

Comptroller/Controller/Auditor

31/12/1983

30/11/2012

Martin Feldstein

Director/Board Member	31/12/2001	03/06/2012
Independent Dir/Board Member	14/04/2011	03/06/2012

Frank M. Deane

Director/Board Member	04/05/2011	05/05/2011
Corporate Officer/Principal	31/12/1985	31/12/2011

Anne Nobles

Director/Board Member	04/05/2011	06/09/2011
General Counsel	31/12/1989	31/12/2011

Alex Michael Azar

Public Communications Contact	31/05/2007	31/03/2009
Corporate Officer/Principal	31/03/2009	30/11/2011

David Bredt

Corporate Officer/Principal

31/12/2003

31/12/2010

Gino Santini

Corporate Officer/Principal

31/12/1989

30/11/2010

Steven Paul

Chief Tech/Sci/R&D Officer

31/03/1993

31/01/2010

Anthony John Murphy

Human Resources Officer

31/12/1979

29/04/2009

J. Michael Cook

Director/Board Member

31/12/2004

19/04/2009

Deirdre Connelly

Human Resources Officer	31/12/2002	31/05/2005
Corporate Officer/Principal	31/05/2005	29/01/2009

Charles Golden

Director of Finance/CFO

29/02/1996

29/04/2006

John Edward Victor Rose

Director/Board Member

13/10/2005

Steven C. Beering

Director/Board Member

17/04/2005

Bryan Dunnivant

Chief Operating Officer

31/12/2000

30/12/2004

Vanessah Ng

Corporate Officer/Principal

30/12/2004

Webster Dunbar

Chief Tech/Sci/R&D Officer	31/12/1998	31/12/2002
Corporate Officer/Principal	31/12/2002	31/08/2004

Joseph Zakrzewski

Corporate Officer/Principal

31/12/2002

31/12/2003

Pedro Granadillo

Human Resources Officer	01/01/1970	31/12/2003
Corporate Officer/Principal	01/01/1970	31/12/2003

Scott Priebe

Corporate Officer/Principal

30/12/2003

Alan Breier

Chief Tech/Sci/R&D Officer

31/07/2003

August M. Watanabe

Corporate Officer/Principal

31/05/2003

Brett L. Schmidli

Corporate Officer/Principal

31/12/1991

31/12/2001

Jerome H. Fleisch

Corporate Officer/Principal

31/12/1973

30/12/2001

Stephen W. Kaldor

Corporate Officer/Principal

31/05/1989

30/12/2001

David A. Broecker

Corporate Officer/Principal

31/07/1985

31/12/2000

George Fisher

Director/Board Member

31/12/1999

John T. Boris

Corporate Officer/Principal

01/01/1988

31/12/1997

Lionel Carnot

Corporate Officer/Principal

31/12/1994

31/12/1996

Paul F. Banta

General Counsel

31/05/1987

31/12/1994

Alfred G. Gilman

Director/Board Member	31/12/1994	-
Independent Dir/Board Member	14/04/2011	-

James Cornelius

Director/Board Member	31/12/1982	31/12/1994
Director of Finance/CFO	31/12/1982	31/12/1994

Ron D. Henriksen

Corporate Officer/Principal

01/01/1971

31/12/1993

B. Jack Miller

Human Resources Officer

31/12/1967

30/12/1987

James F. White

Corporate Officer/Principal

Mike Peterson

Corporate Officer/Principal

Simon Li

Corporate Officer/Principal

Rafik H. Bishara

Corporate Officer/Principal

Michael Heffernan

Corporate Officer/Principal

Michael Sherman

Corporate Officer/Principal

Seth D. Goldblum

Corporate Officer/Principal

Erin Markey

Corporate Officer/Principal

Stephen Andrade

Corporate Officer/Principal

Molly Montgomery

Corporate Officer/Principal

Jack Steele

Corporate Officer/Principal

Eric E. Easom

Corporate Officer/Principal

Pat O'Day

Corporate Officer/Principal

Paul A. Hyslop

Corporate Officer/Principal

Dennis W. White

Corporate Officer/Principal

Stephen E. Butts

Corporate Officer/Principal

Ronald A. Matricaria

Corporate Officer/Principal

Robert W. McLaughlin

Corporate Officer/Principal

Wei Zhang

Corporate Officer/Principal

Todd F. Kirschner

Corporate Officer/Principal

Aaron Davidson

Corporate Officer/Principal

John R. Uhrin

Corporate Officer/Principal

Jim R. Baumgardt

Director/Board Member

James B. Lootens

Corporate Secretary

John Barnard

Corporate Officer/Principal

Donald C. Aroborgast

Corporate Officer/Principal

Anton G. Gueth

Corporate Officer/Principal

William D. Huse

Corporate Officer/Principal

Chen-Ming Yu

Corporate Officer/Principal

Kurt Wheeler

Corporate Officer/Principal

Fredric Cohen

Corporate Officer/Principal

Dale M. Edgar

Director/Board Member

Edward S. Dunn

Corporate Officer/Principal

Vincent J. Gurnari

Sales & Marketing

P. Reed Maurer

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	28
Female	9

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	10
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Yes

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.4%); - immunology diseases (9.8%); - neurology (3.3%): primarily drugs used in treating depression and schizophrenia; - other (2%). Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Employees

47,000

Sector

Pharmaceuticals

Calendar

02:03pm - San Antonio Breast Cancer Symposium - Poster No : #PD5-08

More about the company